Export financials
The GEO Group (GEO)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

The GEO Group Income Statement 2025-2007 | GEO
Brief overview of revenue and earnings at The GEO Group
The comparison covers a five-year financial horizon. Revenue at The GEO Group moved from 2.4 billion dollars in 2020 to 2.6 billion dollars in 2025. The five-year change reached +12%, while CAGR stood at 2.3%. The scale of the core business was largely unchanged.
Over the period, EBITDA shifted from 364 million dollars to 390 million dollars, a change of +7%. Operating performance was consistent with the change in sales. The EBITDA share of revenue changed from 15.5% to 14.8%. Operating efficiency did not change materially.
The net result moved from $113 million to $254 million, or +125%. Net profit ended the five years at a local peak.
The market value of the business moved from $999 million to $2 billion, or +102.6%. The market broadly confirmed the positive direction of the business.
Financial takeaway
The financial profile remains mixed, with strengths and risks moving in different directions. Key strengths include a stronger final result and stable operating profitability. The overall view is constrained by weak sales momentum. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement The GEO Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.02 B | 3.59 B | 1.5 B | 1.09 B | 933 M | 999 M | 1.93 B | 2.7 B | 2.71 B | 3.04 B | 2.18 B | 3.15 B | 2.38 B | 750 M | 859 M | 692 M | 779 M | - |
Shares |
137 M | 131 M | 122 M | 121 M | 120 M | 120 M | 119 M | 120 M | 120 M | 111 M | 111 M | 108 M | 107 M | 64 M | 52.4 M | 50.9 M | 50.5 M | - |
Historical Prices |
14.7 | 27.3 | 12.3 | 9.01 | 7.75 | 8.34 | 13.7 | 14.9 | 16.4 | 15.5 | 11.4 | 15 | 11.2 | 7.66 | 4.51 | 13.6 | 15.4 | 18.6 |
Net Income |
254 M | 32 M | 107 M | 172 M | 77.4 M | 113 M | 167 M | 145 M | 146 M | 149 M | 139 M | 144 M | 115 M | 78.6 M | 63.5 M | 66 M | 58.9 M | - |
Revenue |
2.63 B | 2.42 B | 2.41 B | 2.38 B | 2.26 B | 2.35 B | 2.48 B | 2.33 B | 2.26 B | 2.18 B | 1.84 B | 1.69 B | 1.52 B | 1.61 B | 1.27 B | - | - | - |
Gross Profit |
- | - | - | - | - | - | 617 M | 576 M | 563 M | 529 M | 480 M | 446 M | 397 M | 391 M | 295 M | - | - | - |
Operating Income |
257 M | 310 M | 352 M | 384 M | 288 M | 229 M | 303 M | 265 M | 248 M | 266 M | 236 M | 235 M | 185 M | 184 M | 127 M | 29.5 M | 114 M | - |
Interest Expense |
161 M | 191 M | 218 M | 165 M | 129 M | 127 M | 151 M | 150 M | 148 M | 129 M | 106 M | 87.4 M | 83 M | 82.2 M | 40.7 M | 28.5 M | 30.2 M | - |
EBITDA |
390 M | 436 M | 478 M | 517 M | 423 M | 364 M | 431 M | 391 M | 373 M | 380 M | 342 M | 331 M | 280 M | 278 M | 181 M | 68.8 M | 152 M | - |
Operating Expenses |
- | - | - | - | - | - | 317 M | 311 M | 315 M | 264 M | 244 M | 211 M | 212 M | 199 M | 162 M | - | - | - |
General and Administrative Expenses |
236 M | 213 M | 191 M | 197 M | 204 M | 193 M | 186 M | 185 M | 190 M | 149 M | 137 M | 115 M | 117 M | 114 M | 106 M | 69.2 M | 69.2 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement The GEO Group
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
130 M | 131 M | 133 M | - | 138 M | 139 M | 137 M | 140 M | 136 M | 131 M | 122 M | 126 M | 122 M | 122 M | 121 M | 124 M | 121 M | 121 M | 121 M | 122 M | 121 M | 120 M | 120 M | 121 M | 120 M | 120 M | 119 M | 121 M | 119 M | 119 M | 119 M | 121 M | 120 M | 120 M | 122 M | 124 M | 122 M | 122 M | 114 M | 113 M | 111 M | 111 M | 111 M | 74.6 M | 73.8 M | 73.7 M | 73.5 M | 74.2 M | 72.4 M | 71.7 M | 71.4 M | 71.7 M | 71.2 M | 71.1 M | 70.8 M | 71.1 M | 60.9 M | 60.8 M | 60.8 M | 64.4 M | 63.3 M | 64.5 M | 64.3 M | - | 57.8 M | 48.8 M |
Net Income |
49.2 M | 47.5 M | 38.3 M | - | 174 M | 29.1 M | 19.6 M | - | 26.3 M | -32.5 M | 22.7 M | - | 24.5 M | 29.6 M | 28 M | - | 38.3 M | 53.7 M | 38.2 M | - | 34.7 M | 42 M | 50.5 M | 11.9 M | 39.2 M | 36.7 M | 25.2 M | 38 M | 45.9 M | 41.9 M | 40.7 M | 33.4 M | 39.3 M | 37.4 M | 35 M | 36.3 M | 38.5 M | 31 M | 40.4 M | 49.3 M | 43.7 M | 23.2 M | 32.4 M | 44 M | 38.3 M | 28.3 M | 28.8 M | 38 M | 39 M | 38.9 M | 28 M | 27.6 M | 29.9 M | 34.2 M | 23.4 M | 81.6 M | 15.6 M | 22.5 M | 15 M | - | 21.5 M | 21.6 M | 16.8 M | - | 5.28 M | 17 M |
Revenue |
761 M | 732 M | 705 M | - | 682 M | 636 M | 605 M | - | 603 M | 607 M | 606 M | - | 603 M | 594 M | 608 M | - | 617 M | 588 M | 551 M | - | 557 M | 565 M | 576 M | 578 M | 579 M | 588 M | 605 M | 622 M | 632 M | 614 M | 611 M | 599 M | 584 M | 584 M | 2 M | 569 M | 1.34 M | 577 M | 551 M | - | 1.69 M | 548 M | 510 M | - | 1.34 M | 1.12 M | 427 M | - | 458 M | 413 M | 393 M | - | 380 M | 382 M | 377 M | - | 369 M | 430 K | 748 K | - | 272 K | 1.42 M | 662 K | - | - | - |
Operating Income |
102 M | 102 M | 89.3 M | - | 40.7 M | 72 M | 61 M | - | 82.4 M | 80.1 M | 79.6 M | - | 83.6 M | 92.4 M | 92.7 M | - | 98.1 M | 95.1 M | 81.5 M | - | 74 M | 72.4 M | 65.6 M | 38 M | 64.7 M | 64.8 M | 56.2 M | 66.3 M | 78.2 M | 81.2 M | 74.8 M | 63.5 M | 69.8 M | 67 M | 64.4 M | 66.5 M | 62.9 M | 54.6 M | 64.4 M | 68 M | 72.5 M | 66 M | 59.2 M | 66.7 M | 63 M | 53.3 M | 52.7 M | 62 M | 63.3 M | 60.9 M | 48.6 M | 48 M | 44.8 M | 51.4 M | 41.3 M | 39.3 M | 51.6 M | 52.9 M | 40.5 M | 47.3 M | 47.3 M | 46.3 M | 38.7 M | 43.4 M | 29.5 M | 33 M |
Interest Expense |
-36.1 M | 38.6 M | 38.3 M | - | 38.2 M | 41.9 M | 42.4 M | - | 45.5 M | 50.6 M | 51.3 M | - | 55.8 M | 55 M | 54.3 M | - | 46.5 M | 33.2 M | 31.6 M | - | 32.5 M | 32.1 M | 31.8 M | - | 30.7 M | 30.6 M | 34.2 M | - | 36.6 M | 38.9 M | 40.3 M | - | 38 M | 36.3 M | 35.9 M | - | 38.7 M | 36 M | 35 M | - | 33.4 M | 31.1 M | 29.4 M | - | 27.3 M | 26.7 M | 24.6 M | - | 21.4 M | 20.6 M | 20.7 M | - | 21.6 M | 21.1 M | 19.3 M | - | 20.6 M | 20.6 M | 20.8 M | - | 19.3 M | 19.4 M | 17 M | - | 11.9 M | 8.45 M |
EBITDA |
104 M | 170 M | 123 M | - | 73.7 M | 105 M | 93.1 M | - | 114 M | 111 M | 111 M | - | 115 M | 124 M | 125 M | - | 130 M | 127 M | 117 M | - | 174 M | 140 M | 99.7 M | 38 M | 165 M | 132 M | 89.5 M | 66.3 M | 175 M | 146 M | 107 M | 63.5 M | 164 M | 130 M | 96.4 M | 66.5 M | 155 M | 115 M | 93.3 M | 68 M | 158 M | 123 M | 87.6 M | 66.7 M | 142 M | 105 M | 77.6 M | 62 M | 135 M | 109 M | 72.7 M | 48 M | 115 M | 98 M | 64.2 M | 39.3 M | 120 M | 98.1 M | 62.7 M | 47.3 M | 109 M | 85.9 M | 57.5 M | 43.4 M | 42.9 M | 42.5 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -38 M | - | - | - | -66.3 M | - | - | - | -63.5 M | - | - | - | -66.5 M | - | - | - | -68 M | - | - | - | -66.7 M | - | - | - | -62 M | - | - | - | -48 M | - | - | - | -39.3 M | - | - | - | -47.3 M | - | - | - | - | - | - |
General and Administrative Expenses |
72.1 M | 65.5 M | 60.6 M | - | 62.1 M | 56.2 M | 57.7 M | - | 47.1 M | 52.2 M | 53.1 M | - | 47.4 M | 41.7 M | 50.1 M | - | 50 M | 49.3 M | 48.6 M | - | 50.5 M | 54.7 M | 48.5 M | - | 46.6 M | 45.5 M | 53.8 M | - | 48.5 M | 47.3 M | 46.4 M | - | 47.6 M | 47.4 M | 41.8 M | - | 49.1 M | 52.2 M | 42.6 M | - | 37.5 M | 36.9 M | 34.1 M | - | 33.7 M | 32.2 M | 31.8 M | - | 28.3 M | 28.1 M | 28.5 M | - | 27.2 M | 27.4 M | 32 M | - | 26.4 M | 26.1 M | 26.6 M | - | 25.9 M | 27.7 M | 32.8 M | - | 33.9 M | 20.7 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company The GEO Group (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Reit healthcare industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Sabra Health Care REIT
SBRA
|
$ 21.32 | -0.7 % | $ 5.14 B | ||
|
Ventas
VTR
|
$ 90.34 | 0.95 % | $ 41.1 B | ||
|
Welltower
WELL
|
$ 247.68 | 0.48 % | $ 165 B | ||
|
LTC Properties
LTC
|
$ 44.52 | -1.02 % | $ 2.06 B | ||
|
National Health Investors
NHI
|
$ 67.78 | -4.84 % | $ 3.18 B | ||
|
Omega Healthcare Investors
OHI
|
$ 48.69 | -0.29 % | $ 14.2 B | ||
|
Global Medical REIT
GMRE
|
- | - | $ 2.37 B | ||
|
Healthpeak Properties
PEAK
|
- | 2.09 % | $ 9.35 B |